References - Signal Processing in MRS with Biomedical Applications - page 426

[305] Kuznetsov, Y.E., Caramanos, Z., Antel, S.B., Preul, M.C., Leblanc,
R., Villemure, J.G., Pokrupa., R., Olivier, A., Sadikot, A., and
Arnold, D.L., Proton magnetic resonance spectroscopic imaging can
predict length of survival in patients with supratentorial gliomas,
Neurosurgery, 53, 565 - 576, 2003.
[306] Arus, C., Tumors and spectroscopy, Magn. Reson. Mater. Phys. Biol.
Med., 15 (Suppl. 1), 38, 2002.
[307] Aboagye, E.O., and Bhujwalla, Z.M., Malignant transformation alters
membrane choline phospholipid metabolism of human mammary
epithelial cells, Cancer Res., 59, 80 - 84, 1999.
[308] Glunde, K., Jie, C., and Bhujwalla, Z.M., Molecular causes of the
aberrant choline phospholipid metabolism in breast cancer, Cancer
Res., 64, 4270 - 4276, 2004.
[309] KatzBrull, R., Margalit, R., and Degani, H., Differential routing of
choline in implanted breast cancer and normal organs, Magn. Reson.
Med., 46, 31 - 38, 2001.
[310] Ackerstaff, E., Pflug, B.R., Nelson, J.B., and Bhujwalla, Z.M.,
Detection of increased choline compounds with proton nuclear
magnetic resonance spectroscopy subsequent to malignant
transformation of human prostatic epithelial cells, Cancer Res., 61,
3599 - 3603, 2001.
[311] Pecorelli, S., Favalli, G., Zigliani, L., and Odicino, F., Cancer in
women, Int. J. Gynaecol. Obstet., 82, 369 - 379, 2003.
[312] Brewer, M.A., Johnson, K., Follen, M., Gershenson, D., and Bast, R.,
Prevention of ovarian cancer: intraepithelial neoplasia, Clin. Cancer
Res., 9, 20 - 30, 2003.
[313] Ashworth, A., Balkwill, F., Bast, R.C., Berek, J.S., Kaye, A., Boyd,
J.A., Mills, G., Weinstein, J.N., Woolley, K., and Workman, P.,
Opportunities and challenges in ovarian cancer research, a perspective
from the 11th Ovarian cancer action/HHMT Forum, Lake Como,
March 2007, Gynecol. Oncol., 108, 652 - 657, 2008.
[314] Woodward, E.R., Sleightholme, H.V., Considine, A.M., Williamson,
S., McHugo, J.M., and Cruger, D.G., Annual surveillance by CA125
and transvaginal ultrasound for ovarian cancer in both highrisk and
population risk women is ineffective, Br. J. Obstet. Gynaecol., 114,
1500 - 1509, 2007.
[315] Bhoola, S., and Hoskins, W.J., Diagnosis and management of
epithelial ovarian cancer, Obstet. Gynecol., 107, 1399 - 1410, 2006.